Notifications
Clear all
Topic starter
25/06/2026 3:16 pm
TL;DR: The White House Health Tech Ecosystem Initiative expands FHIR-based interoperability across providers, payers, and apps by 2026, but experts warn that privacy, consent, and API governance will determine whether data movement stays secure, according to Imprivata. The real challenge is not connectivity, but enforceable identity, access, and consent controls that keep third-party exposure and over-broad token scope from outpacing governance.
NHIMG editorial — based on content published by Imprivata: Experts Say White House Health Tech Initiative Raises Data Privacy Concerns, Urging Healthcare Organizations to Take Stronger Security and Compliance Measures
Questions worth separating out
Q: How should healthcare organisations govern FHIR API access without weakening interoperability?
A: They should treat each API integration as a named identity with a documented purpose, narrow scope, and explicit revocation path.
Q: Why do third-party health apps create a larger privacy and security risk than internal systems?
A: Third-party apps often sit outside the same governance, monitoring, and contractual controls as internal systems, yet they may still receive access to sensitive data through shared APIs.
Q: What breaks when healthcare API scopes are too broad?
A: Broad scopes turn a single integration into a high-blast-radius access path.
Practitioner guidance
- Inventory every FHIR-linked identity Build a complete register of service accounts, API clients, tokens, and third-party apps that can touch PHI, then classify each by owner, purpose, and revocation path.
- Bind consent to policy enforcement Translate patient consent and data-use obligations into access policies that can be evaluated at request time, rather than relying on static privacy notices.
- Reduce token scope and lifetime Replace broad or persistent API permissions with narrowly scoped credentials and explicit expiry, especially for bulk-export or delegated data flows.
What's in the full article
Imprivata's full article covers the operational detail this post intentionally leaves for the source:
- The article expands on how FHIR-based healthcare interoperability creates new identity, consent, and privacy obligations across providers and app vendors.
- It includes the specific security and compliance measures experts recommend for shared-device use, patient verification, and sensitive transaction monitoring.
- The source also explains why long-lived tokens, bulk-export staging, and third-party access require tighter oversight than policy language alone can provide.
👉 Read Imprivata's analysis of healthcare interoperability, privacy, and identity risk →
Health tech interoperability and identity controls: what teams need now?
Explore further
25/06/2026 4:42 pm
Identity has become the trust boundary for healthcare interoperability. The initiative is not simply about moving more data through FHIR APIs. It is about deciding which identities, applications, and vendors can participate in clinical data exchange without turning every integration into an implicit trust grant. That is a governance problem before it is a technical one, and it requires IAM, IGA, and consent to operate as a single control set. Practitioners should treat the interoperability layer as an identity programme, not an app-integration backlog.
A few things that frame the scale:
- 85% of organisations lack full visibility into third-party vendors connected via OAuth apps, according to The State of Non-Human Identity Security.
- A separate finding from the same research shows that only 1.5 out of 10 organisations are highly confident in their ability to secure NHIs, underscoring how weak visibility and weak assurance reinforce each other.
A question worth separating out:
Q: Who is accountable when a connected health app mishandles patient data?
A: Accountability should be shared across the organisation that granted access, the vendor operating the app, and the team responsible for consent and logging. If policy cannot show who approved the access, under what terms, and how it will be revoked, the governance model is incomplete.
👉 Read our full editorial: White House health tech initiative raises privacy and identity risk
